Trilantic North America Makes Growth Investment in SOFIE Biosciences
January 28, 2024
Trilantic North America has made a substantial growth investment in SOFIE Biosciences, a founder-led radiopharmacy and radiopharmaceutical CDMO headquartered in Dulles, Virginia. The SOFIE founding team will retain a meaningful equity stake and continue to lead the business; proceeds will be used to expand capacity and points of presence to improve patient access to radiopharmaceuticals.
- Buyers
- Trilantic North America
- Targets
- SOFIE Biosciences
- Industry
- Healthcare Services
- Location
- Virginia, United States
- Transaction Type
- Growth capital
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.